These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 35163735)

  • 1. The Role of Oncostatin M and Its Receptor Complexes in Cardiomyocyte Protection, Regeneration, and Failure.
    Kubin T; Gajawada P; Bramlage P; Hein S; Berge B; Cetinkaya A; Burger H; Schönburg M; Schaper W; Choi YH; Richter M
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OSM/OSMR and Interleukin 6 Family Cytokines in Physiological and Pathological Condition.
    Lantieri F; Bachetti T
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.
    Adrian-Segarra JM; Schindler N; Gajawada P; Lörchner H; Braun T; Pöling J
    J Biol Chem; 2018 May; 293(18):7017-7029. PubMed ID: 29511087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.
    Walker EC; Johnson RW; Hu Y; Brennan HJ; Poulton IJ; Zhang JG; Jenkins BJ; Smyth GK; Nicola NA; Sims NA
    J Biol Chem; 2016 Oct; 291(41):21703-21716. PubMed ID: 27539849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant Activation of OSM and LIF Receptor by a Dual-Specific hlOSM Variant Confers Cardioprotection after Myocardial Infarction in Mice.
    Lörchner H; Adrian-Segarra JM; Waechter C; Wagner R; Góes ME; Brachmann N; Sreenivasan K; Wietelmann A; Günther S; Doll N; Braun T; Pöling J
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gp130 Controls Cardiomyocyte Proliferation and Heart Regeneration.
    Li Y; Feng J; Song S; Li H; Yang H; Zhou B; Li Y; Yue Z; Lian H; Liu L; Hu S; Nie Y
    Circulation; 2020 Sep; 142(10):967-982. PubMed ID: 32600062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice.
    Adrian-Segarra JM; Sreenivasan K; Gajawada P; Lörchner H; Braun T; Pöling J
    J Biol Chem; 2018 Dec; 293(52):20181-20199. PubMed ID: 30373773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by modulating macrophages and OSM/LIFR/STAT3 signalling.
    Feng Y; Yuan Y; Xia H; Wang Z; Che Y; Hu Z; Deng J; Li F; Wu Q; Bian Z; Zhou H; Shen D; Tang Q
    J Transl Med; 2023 Apr; 21(1):290. PubMed ID: 37120549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
    Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
    Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of IL-6/gp130 family receptor expression reveals that in contrast to astroglia, microglia lack the oncostatin M receptor and functional responses to oncostatin M.
    Hsu MP; Frausto R; Rose-John S; Campbell IL
    Glia; 2015 Jan; 63(1):132-41. PubMed ID: 25103368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered interleukin-6-derived cytokines recruit artificial receptor complexes and disclose CNTF signaling via the OSMR.
    Rafii P; Cruz PR; Ettich J; Seibel C; Padrini G; Wittich C; Lang A; Petzsch P; Köhrer K; Moll JM; Floss DM; Scheller J
    J Biol Chem; 2024 May; 300(5):107251. PubMed ID: 38569939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
    Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
    J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the rat oncostatin M receptor complex which resembles the human, but differs from the murine cytokine receptor.
    Drechsler J; Grötzinger J; Hermanns HM
    PLoS One; 2012; 7(8):e43155. PubMed ID: 22937020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncostatin M is a growth factor for Ewing sarcoma.
    David E; Tirode F; Baud'huin M; Guihard P; Laud K; Delattre O; Heymann MF; Heymann D; Redini F; Blanchard F
    Am J Pathol; 2012 Nov; 181(5):1782-95. PubMed ID: 22982441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes.
    Weiss TW; Speidl WS; Kaun C; Rega G; Springer C; Macfelda K; Losert UM; Grant SL; Marro ML; Rhodes AD; Fuernkranz A; Bialy J; Ullrich R; Holzmann P; Pacher R; Maurer G; Huber K; Wojta J
    Cardiovasc Res; 2003 Sep; 59(3):628-38. PubMed ID: 14499864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas.
    Chen D; Chu CY; Chen CY; Yang HC; Chiang YY; Lin TY; Chiang IP; Chuang DY; Yu CC; Chow KC
    J Pathol; 2008 Jul; 215(3):290-9. PubMed ID: 18491353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key role of suppressor of cytokine signaling 3 in regulating gp130 cytokine-induced signaling and limiting chondrocyte responses during murine inflammatory arthritis.
    Liu X; Croker BA; Campbell IK; Gauci SJ; Alexander WS; Tonkin BA; Walsh NC; Linossi EM; Nicholson SE; Lawlor KE; Wicks IP
    Arthritis Rheumatol; 2014 Sep; 66(9):2391-402. PubMed ID: 24839265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
    Malaval L; Liu F; Vernallis AB; Aubin JE
    J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling.
    Kubin T; Pöling J; Kostin S; Gajawada P; Hein S; Rees W; Wietelmann A; Tanaka M; Lörchner H; Schimanski S; Szibor M; Warnecke H; Braun T
    Cell Stem Cell; 2011 Nov; 9(5):420-32. PubMed ID: 22056139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.